The 80th Annual Meeting of The American Psychopathological Association

PROGRAM The 80th Annual Meeting of The American Psychopathological Association in New York City at the St. Moritz Hotel March

SCHIZOPHRENIA:

l-3,

FROM

1990

MIND

TO MOLECULE

ABSTRACT Dr. Nancy C. Andreasen

This program will review recent progress in understanding the clinical symptoms of schizophrenia, the mechanisms that produce the disease, and various approaches to treatment. The psychopathology of schizophrenia will be explored both in terms of the subjective experience involved and the neuralmechanisms that produce clinical phenomena. New areas of emerging research will be examined, including neuroimaging and molecular biology. Approaches to treatment will be examined from the perspectives of basic pharmacology and neurochemistry, the use of conventional and atypical neuroleptics, and the relevance of psychosocial treatments. The program will conclude by examining future directions for research that appear particularly promising, including developmental neuroanatomy and the molecular mechanisms of memory.

THURSDAY, 8:30-9:00

a.m.

1, 1990

Registration PHENOMENOLOGY: THE HUMAN Chair: Dr. Samuel J. Keith

Session I 9:00-9:45

MARCH

Dr. Martin Willick “A Parent’s Perspective”

a.m.

9:45- 10:00 a.m.

Discussion

lO:OO-lo:45 a.m.

Dr. John Strauss “A Clinician-Researcher’s

IO:45 1l:OO a.m.

Discussion

1 1:OO-11:45 a.m.

Laurie Flynn “A Social and Economic

11:45 a.m.- 12:OO p.m.

Discussion

Comprehensive

EXPERIENCE

Psychiatry,

Perspective”

Perspective”

Vol. 3 1, No. 1 (January/February),

1990:

pp 87-89

87

PROGRAM

88

Session II

NEURAL FOUNDATIONS OF CLINICAL PHENOMENA Chair: Philip S. Holzman, Ph.D.

1:30-2:20 p.m.

Dr. Nancy C. Andreasen “Linking Phenomenology (Presidential Address)

2:20-2:30

p.m.

Discussion

2:30-3:20

p.m.

Dr. Ruben Gur “The Neuropsychology

to Neurobiology”

of Schizophrenia”

3:20-3:30

p.m.

Discussion

3:30-4:20

p.m.

Dr. Joel E. Kleinman “The Neuropathology

4:20-4:30

p.m.

Discussion

4:30-520

p.m.

Dr. Adrienne Reveley “Phenomenology, Environmental Twin Studies of Schizophrenia”

5:20-5:30

p.m.

9:30-lo:30

MARCH

2,199O

THE IMPACT OF EMERGING Chair: Dr. Ming T. Tsuang

Session I a.m.

a.m.

Risk, and Genetics:

Discussion

FRIDAY,

8:30-9:30

of Schizophrenia”

Dr. Jay W. Pettegrew “Magnetic Resonance Probe” Dr. Goran Sedvall “PET as a Metabolic

TECHNOLOGIES

as a Structural

and Functional

and Neurochemical

10:30-l 1:30 a.m.

Dr. Raymond R. Crowe “Molecular Genetics”

11:30 a.m.- 12:OO p.m.

Business Meeting

Session II

THE NEED FOR INNOVATIVE Chair: Dr. Herbert Meltzer

Probe”

TREATMENTS

2:00-2:45

p.m.

Dr. Arvid Carlsson “The Search for the Ideal Medications: Developing a Rational Neuropharmacology” (Hoch Award Lecture)

2:45-3:00

p.m.

Discussion

3:00-3:45

p.m.

Dr. John M. Kane “Efficacy, Mechanisms, Atypical Neuroleptics”

and Side Effects of Typical and

3:45-4:00

p.m.

Discussion

4:00-4:45

p.m.

Dr. Thomas H. McGlashan “Psychosocial Treatments:

4:45-5:00

p.m.

Discussion

The Potential

Relationships”

89

PROGRAM

SATURDAY,

MARCH

3, 1990

SCHIZOPHRENIA AND THE FUTURE Chair: Dr. Nina Schooler 9:00-9:45

9:45-10:00

a.m.

a.m.

Dr. Pasko Rakic “Normal Brain Development: of Schizophrenia”

for the Study

Discussion

I O:OO-IO:45 a.m.

Dr. Eric R. Kandel “Molecular Mechanisms

1 I :OO-I I :45 a.m.

Dr. Lewis L. Judd “Implications of a National Schizophrenia”

1I :45 a.m.-l 2:00 p.m.

Implications

Discussion

of Memory” Research

Strategy

to Study